What is AWS Bio-Pharma Technologies?
AWS Bio-Pharma Technologies, LLC is dedicated to delivering cost-effective, integrated equipment solutions tailored for the Bio-Tech, Parenteral, and pharmaceutical manufacturing sectors. The company distinguishes itself by offering innovative and proven manufacturing equipment, supported by a highly trained service staff. With its main office located near Albuquerque, New Mexico, and a secondary site near St. Louis, Missouri, AWS Bio-Pharma ensures efficient customer access and support. Beyond equipment sales, the company provides value-added services, including engineering assistance and consultation, with a unique rebate program for these services against equipment purchases. This comprehensive approach positions AWS Bio-Pharma as a key partner for manufacturers seeking quality equipment and robust support.
How much funding has AWS Bio-Pharma Technologies raised?
AWS Bio-Pharma Technologies has raised a total of $56K across 1 funding round:
Debt
$56K
Debt (2021): $56K with participation from PPP
What's next for AWS Bio-Pharma Technologies?
The recent substantial expansion capital infusion signals a strategic move by AWS Bio-Pharma Technologies to accelerate its market penetration and operational capabilities. As the company operates at a significant Series B/C stage, this investment is expected to facilitate the scaling of its infrastructure, potentially leading to expanded product lines or enhanced service delivery. The focus on engineering assistance and consultation, coupled with equipment sales, suggests a strategy aimed at providing end-to-end solutions for its clientele. Future developments will likely involve leveraging this financing to solidify its position as a leading provider of integrated manufacturing equipment and support services within the pharmaceutical and biotechnology industries.
See full AWS Bio-Pharma Technologies company page
